Last $5.71 USD
Change Today -0.03 / -0.52%
Volume 38.2K
ENZ On Other Exchanges
New York
As of 12:36 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

enzo biochem inc (ENZ) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/2/14 - $6.13
52 Week Low
10/17/13 - $2.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ENZO BIOCHEM INC (ENZ)

enzo biochem inc (ENZ) Related Businessweek News

No Related Businessweek News Found

enzo biochem inc (ENZ) Details

Enzo Biochem, Inc., an integrated life sciences and biotechnology company, is engaged in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 35 patient service centers in New York and New Jersey; and a standalone laboratory in the New York, as well as a full-service phlebotomy, in-house logistics department, and information technology department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment offers its products to scientific experts primarily in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment is involved in research and development of therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company markets its products and services through its direct sales force. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.

423 Employees
Last Reported Date: 10/15/13
Founded in 1976

enzo biochem inc (ENZ) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $555.5K
Co Founder, President, Chief Financial Office...
Total Annual Compensation: $492.7K
Vice President of Corporate Development and I...
Total Annual Compensation: $215.0K
Vice President of Business Development and Ch...
Total Annual Compensation: $226.0K
Compensation as of Fiscal Year 2013.

enzo biochem inc (ENZ) Key Developments

Enzo Biochem Inc.(NYSE:ENZ) added to Russell 2000 Index

Enzo Biochem Inc. will be added to the Russell 2000 Index.

Enzo Biochem Inc.(NYSE:ENZ) added to Russell 3000 Index

Enzo Biochem Inc. will be added to the Russell 3000 Index.

Enzo Biochem Announces Settlement Agreement with PerkinElmer

Enzo Biochem, Inc. along with its subsidiary Enzo Life Sciences, Inc. entered into a Settlement with PerkinElmer, Inc. and PerkinElmer Health Sciences, Inc. with respect to an action between the Company and PerkinElmer before the U.S. District Court, Southern District of New York, Case No 03-CV-3817. PerkinElmer, Inc. has agreed to pay $7,000,000 in escrow in settlement pursuant to the Agreement.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZ:US $5.71 USD -0.03

ENZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Affymetrix Inc $8.42 USD -0.08
Computer Programs & Systems Inc $60.36 USD -0.15
HealthStream Inc $25.69 USD +0.27
Luminex Corp $19.67 USD +0.31
Merge Healthcare Inc $2.45 USD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation ENZ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.6x
Price/Book 6.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at